- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Proteomics
Volume 2010 (2010), Article ID 726968, 14 pages
Comparative Proteomic Analysis of Proteins Involved in the Tumorigenic Process of Seminal Vesicle Carcinoma in Transgenic Mice
1Genomics Research Center, Academia Sinica, Taipei, Taiwan
2National Applied Research Laboratories, National Laboratory Animal Center, Taipei, Taiwan
3Institute of Information Science, Academia Sinica, Taipei, Taiwan
4Department of Medical Research, Mackay Memorial Hospital, Tamshui, Taiwan
5Chemistry Department, National Taiwan University, Taipei, Taiwan
6Institute of Atomic and Molecular Sciences, Academia Sinica, Taipei, Taiwan
Received 18 December 2009; Accepted 18 February 2010
Academic Editor: Alexander I. Archakov
Copyright © 2010 Wei-Chao Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- T. Ralf and E. Peter, “Primary adenocarcinoma of the seminal vesicles,” Journal of Urology, vol. 168, no. 5, pp. 1891–1896, 2002.
- L. Egevad, R. Ehrnström, U. Håkansson, and M. Grabe, “Primary seminal vesicle carcinoma detected at transurethral resection of prostate,” Urology, vol. 69, no. 4, pp. 778.e11–778.e13, 2007.
- A. Billis, D. A. Teixeira, R. F. Stelini, M. M. Quintal, M. S. Guimaraães, and U. Ferreira, “Seminal vesicle invasion in radical prostatectomies: which is the most common route of invasion?” International Urology and Nephrology, vol. 39, no. 4, pp. 1097–1102, 2007.
- B. Peitz and P. Olds-Clarke, “Effects of seminal vesicle removal on fertility and uterine sperm motility in the house mouse,” Biology of Reproduction, vol. 35, no. 3, pp. 608–617, 1986.
- A. Lundwall, J. Malm, A. Clauss, C. Valtonen-Andre, and A. Y. Olsson, “Molecular cloning of complementary DNA encoding mouse seminal vesicle-secreted protein SVS I and demonstration of homology with copper amine oxidases,” Biology of Reproduction, vol. 69, no. 6, pp. 1923–1930, 2003.
- A. Lundwall, “The cloning of a rapidly evolving seminal-vesicle-transcribed gene encoding the major clot-forming protein of mouse semen,” European Journal of Biochemistry, vol. 235, no. 1–2, pp. 424–430, 1996.
- S.-H. Li, R. K. Lee, Y.-L. Hsiao, and Y.-H. Chen, “Demonstration of a glycoprotein derived from the Ceacam10 gene in mouse seminal vesicle secretions,” Biology of Reproduction, vol. 73, no. 3, pp. 546–553, 2005.
- J.-D. Vassalli, J. Huarte, D. Bosco, et al., “Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle,” EMBO Journal, vol. 12, no. 5, pp. 1871–1878, 1993.
- L.-Y. Chen, Y.-H. Lin, M.-L. Lai, and Y.-H. Chen, “Developmental profile of a caltrin-like protease inhibitor, P12, in mouse seminal vesicle and characterization of its binding sites on sperm surface,” Biology of Reproduction, vol. 59, no. 6, pp. 1498–1505, 1998.
- T. D. Veenstra, T. P. Conrads, B. L. Hood, A. M. Avellino, R. G. Ellenbogen, and R. S. Morrison, “Biomarkers: mining the biofluid proteome,” Molecular and Cellular Proteomics, vol. 4, no. 4, pp. 409–418, 2005.
- W. Haas, B. K. Faherty, S. A. Gerber, et al., “Optimization and use of peptide mass measurement accuracy in shotgun proteomics,” Molecular and Cellular Proteomics, vol. 5, no. 7, pp. 1326–1337, 2006.
- G. A. de Souza, L. M. F. Godoy, and M. Mann, “Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors,” Genome Biology, vol. 7, no. 8, article R72, 2006.
- J. Adachi, C. Kumar, Y. Zhang, J. V. Olsen, and M. Mann, “The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins,” Genome Biology, vol. 7, no. 9, article R80, 2006.
- B. Pilch and M. Mann, “Large-scale and high-confidence proteomic analysis of human seminal plasma,” Genome Biology, vol. 7, no. 5, article R40, 2006.
- R. Etzioni, N. Urban, S. Ramsey, et al., “The case for early detection,” Nature Reviews Cancer, vol. 3, no. 4, pp. 243–252, 2003.
- M. A. Reymond and W. Schlegel, “Proteomics in cancer,” Advances in Clinical Chemistry, vol. 44, pp. 103–142, 2007.
- N. M. Greenberg, F. DeMayo, M. J. Finegold, et al., “Prostate cancer in a transgenic mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 8, pp. 3439–3443, 1995.
- C.-C. Tsou, C.-F. Tsai, Y.-H. Tsui, et al., “IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation,” Molecular and Cellular Proteomics, vol. 9, no. 1, pp. 131–144, 2010.
- H.-J. Lin, C.-W. Luo, and Y.-H. Chen, “Localization of the transglutaminase cross-linking site in SVS III, a novel glycoprotein secreted from mouse seminal vesicle,” Journal of Biological Chemistry, vol. 277, no. 5, pp. 3632–3639, 2002.
- C.-W. Luo, H.-J. Lin, and Y.-H. Chen, “A novel heat-labile phospholipid-binding protein, SVS VII, in mouse seminal vesicle as a sperm motility enhancer,” Journal of Biological Chemistry, vol. 276, no. 10, pp. 6913–6921, 2001.
- S.-H. Li, R. K.-K. Lee, M.-H. Lin, et al., “SSLP-1, a secreted Ly-6 protein purified from mouse seminal vesicle fluid,” Reproduction, vol. 132, no. 3, pp. 493–500, 2006.
- M.-H. Lin, R. K.-K. Lee, Y.-M. Hwu, et al., “SPINKL, a Kazal-type serine protease inhibitor-like protein purified from mouse seminal vesicle fluid, is able to inhibit sperm capacitation,” Reproduction, vol. 136, no. 5, pp. 559–571, 2008.
- J. C. Silva, M. V. Gorenstein, G.-Z. Li, J. P. C. Vissers, and S. J. Geromanos, “Absolute quantification of proteins by LCM: a virtue of parallel MS acquisition,” Molecular and Cellular Proteomics, vol. 5, no. 1, pp. 144–156, 2006.
- M. D. Abramoff, P. J. Magalhaes, and S. J. Ram, “Image processing with imageJ,” Biophotonics International, vol. 11, no. 7, pp. 36–42, 2004.
- S. Matsuba, Y. Suga, K. Ishidoh, et al., “Sulfhydryl oxidase () from mouse epidermis: molecular cloning, nucleotide sequence, and expression of recombinant protein in the cultured cells,” Journal of Dermatological Science, vol. 30, no. 1, pp. 50–62, 2002.
- C. Morel, P. Adami, J.-F. Musard, D. Duval, J. Radom, and M. Jouvenot, “Involvement of sulfhydryl oxidase QSOX1 in the protection of cells against oxidative stress-induced apoptosis,” Experimental Cell Research, vol. 313, no. 19, pp. 3971–3982, 2007.
- B. L. Moss, L. Taubner, Y. K. Sample, D. A. Kazmin, V. Copié, and J. R. Starkey, “Tumor shedding of laminin binding protein modulates angiostatin production in vitro and interferes with plasmin-derived inhibition of angiogenesis in aortic ring cultures,” International Journal of Cancer, vol. 118, no. 10, pp. 2421–2432, 2006.
- Y. Li and Y.-Y. Lu, “Applying a highly specific and reproducible cDNA RDA method to clone garlic up-regulated genes in human gastric cancer cells,” World Journal of Gastroenterology, vol. 8, no. 2, pp. 213–216, 2002.
- S. Thelin-Järnum, C. Lassen, I. Panagopoulos, N. Mandahl, and P. Aman, “Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas,” International Journal of Cancer, vol. 83, no. 1, pp. 30–33, 1999.
- J. Kawai, A. Shinagawa, K. Shibata, et al., “Functional annotation of a full-length mouse cDNA collection,” Nature, vol. 409, no. 6821, pp. 685–690, 2001.
- C. Guilbaud, A. M. Simon, G. Veyssiere, and C. Jean, “Cloning and sequence analysis of a cDNA encoding an androgen-dependent mouse seminal vesicle secretory protein,” Journal of Molecular Endocrinology, vol. 10, no. 3, pp. 279–288, 1993.
- H.-J. Kim, I. Sohng, C.-H. Hwang, and J.-Y. Park, “Cytokeratin-20 and seminal vesicle secretory protein VI as possible marker proteins in urinary bladder preneoplastic lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine,” International Journal of Urology, vol. 13, no. 2, pp. 142–147, 2006.
- N. Kawano and M. Yoshida, “Semen-coagulating protein, SVS2, in mouse seminal plasma controls sperm fertility,” Biology of Reproduction, vol. 76, no. 3, pp. 353–361, 2007.
- Y. Zhang, Z. Wang, H. Liu, F. J. Giles, and S. H. Lim, “Pattern of gene expression and immune responses to Semenogelin 1 in chronic hematologic malignancies,” Journal of Immunotherapy, vol. 26, no. 6, pp. 461–467, 2003.
- A. Clauss, H. Lilja, and A. Lundwall, “The evolution of a genetic locus encoding small serine proteinase inhibitors,” Biochemical and Biophysical Research Communications, vol. 333, no. 2, pp. 383–389, 2005.
- L.-C. Yu, J.-L. Chen, W.-B. Tsai, and Y.-H. Chen, “Primary structure and characterization of an androgen-stimulated autoantigen purified from mouse seminal-vesicle secretion,” Biochemical Journal, vol. 296, no. 3, pp. 571–576, 1993.
- Y. H. Chen, B. T. Pentecost, J. A. McLachlan, and C. T. Teng, “The androgen-dependent mouse seminal vesicle secretory protein IV: characterization and complementary deoxyribonucleic acid cloning,” Molecular Endocrinology, vol. 1, no. 10, pp. 707–716, 1987.
- E. De Lamirande, K. Yoshida, T. M. Yoshiike, T. Iwamoto, and C. Gagnon, “Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process,” Journal of Andrology, vol. 22, no. 4, pp. 672–679, 2001.
- S. Dorus, P. D. Evans, G. J. Wyckoff, S. S. Choi, and B. T. Lahn, “Rate of molecular evolution of the seminal protein gene SEMG2 correlates with levels of female promiscuity,” Nature Genetics, vol. 36, no. 12, pp. 1326–1329, 2004.
- S. E. Harris, M. A. Harris, C. M. Johnson, and M. F. Bean, “Structural characterization of the rat seminal vesicle secretion II protein and gene,” Journal of Biological Chemistry, vol. 265, no. 17, pp. 9896–9903, 1990.
- T. Iwamoto, H. Tanaka, T. Osada, T. Shinagawa, Y. Osamura, and C. Gagnon, “Origin of a sperm motility inhibitor from boar seminal plasma,” Molecular Reproduction and Development, vol. 36, no. 4, pp. 475–481, 1993.
- S. M. Weis and D. A. Cheresh, “Pathophysiological consequences of VEGF-induced vascular permeability,” Nature, vol. 437, no. 7058, pp. 497–504, 2005.
- K. Mann and M. Mann, “The chicken egg yolk plasma and granule proteomes,” Proteomics, vol. 8, no. 1, pp. 178–191, 2008.
- B.-B. Gao, L. Stuart, and E. P. Feener, “Label-free quantitative analysis of one-dimensional PAGE LC/MS/MS proteome: application on angiotensin II-stimulated smooth muscle cells secretome,” Molecular and Cellular Proteomics, vol. 7, no. 12, pp. 2399–2409, 2008.